Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 217-101-2 | CAS number: 1739-84-0
Specific investigations: other studies
Administrative data
- Endpoint:
- biochemical or cellular interactions
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Basic data given, acceptable for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- The effect of Histamine H2 Receptor Antagonist on Platelet Aggregation in Man
- Author:
- Horton MA, Amos RJ and Jones JJ
- Year:
- 1 983
- Bibliographic source:
- Scand J Haematol (1983) 31, 15-19
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- The in vitro effects on platelet aggregation of various imidazole (cimetidine, oxmetidine, burinamide. metiamide) and non-imidazole (ranitidine) histamine H2 receptor antagonists and structural analogues of imadazole. Platelet aggregation was studied using and ADG Intruments aggregometer. Effects were measured in vitro by preincubation of platelet rich plasma with 20 µl or test substance for 1 minute.
- GLP compliance:
- no
- Type of method:
- in vitro
- Endpoint addressed:
- other: Platelet aggregation
Test material
- Reference substance name:
- 1,2-dimethylimidazole
- EC Number:
- 217-101-2
- EC Name:
- 1,2-dimethylimidazole
- Cas Number:
- 1739-84-0
- Molecular formula:
- C5H8N2
- IUPAC Name:
- 1,2-dimethyl-1H-imidazole
- Details on test material:
- - Name of test substance (as cited in study report): 1,2-Dimethylimidazol
Constituent 1
Test animals
- Details on test animals or test system and environmental conditions:
- Platelet rich plasma (PRP) was obtained form citrated blood (1:9, citrate 3.8 %: whole blood) from 6 normal male volunteers using standard methods; all had been drug free for at least 14 days. Aggregation was induced in 200 µl of PRP by the addition of 20 µl ADP at final concentrations of 20, 10, 5, 2, 1 and 0.4 µmol/l un 5 and 20 µl of collagen suspension.
Administration / exposure
- Details on study design:
- - Tested dose range: 30, 250, 500, 1000 µmol/l
Results and discussion
- Details on results:
- The test substance showed up to the highest tested concentration of 1000 µmol/l no reduction in the aggregation rate in comparison to control.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
